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Abstract
Background: The emergence of  multiple-drug resistance bacteria has become a major threat and thus calls for an urgent need 
to search for new effective and safe anti-bacterial agents.
Objectives: This study aims to evaluate the anticancer and antibacterial activities of  secondary metabolites from Penicillium sp., 
an endophytic fungus associated with leaves of  Garcinia nobilis.
Methods: The culture filtrate from the fermentation of  Penicillium sp. was extracted and analyzed by liquid chromatography–
mass spectrometry, and the major metabolites were isolated and identified by spectroscopic analyses and by comparison with 
published data.  The antibacterial activity of  the compounds was assessed by broth microdilution method while the anticancer 
activity was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
Results: The fractionation of  the crude extract afforded penialidin A-C (1-3), citromycetin (4), p-hydroxyphenylglyoxalaldoxime 
(5) and brefelfin A (6). All of  the compounds tested here showed antibacterial activity (MIC = 0.50 – 128 µg/mL) against Gram-
negative multi-drug resistance bacteria, Vibrio cholerae (causative agent of  dreadful disease cholera) and Shigella flexneri (causative 
agent of  shigellosis), as well as the significant anticancer activity (LC50 = 0.88 – 9.21 µg/mL) against HeLa cells.
Conclusion: The results obtained indicate that compounds 1-6 showed good antibacterial and anticancer activities with no 
toxicity to human red blood cells and normal Vero cells.
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Resistance to antibiotics remains a global challenge to the 
healthcare sector in a large part of  the world in both de-
veloping and developed countries. The spread of  multi-
drug resistant (MDR) bacteria in hospital and community 
settings remains a widely unresolved problem and a heavy 
burden to health services. Despite advances in antibiotic 
therapy, infectious complications remain an important 
cause of  mortality and morbidity among hospitalized pa-
tients.1
Natural products are organic compounds formed by liv-
ing organisms in response to external stimuli such as nu-
tritional changes, infection and competition. Biologically 
active natural products produced by plants, animals, in-
sects, fungi, bacteria and protozoans have been isolated 
to be used in pharmaceutical drug discovery and design.2,3 
Endophytes are microbes which reside in living plant tis-
sues without causing injury or diseases to the hosts.4,5 
Most of  endophytes are capable of  producing active me-
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tabolites and some of  these compounds are proven to 
have medical values. For example, terpenoids, alkaloids, 
phenylpropanoids, aliphatic compounds, polyketides and 
peptides isolated from endophytic fungi have been re-
ported to possess antimicrobial and cytotoxic activities.6
In our continuous search of  antibacterial and anticancer 
drugs from natural source, we targeted one endophytic 
fungus Penicillium sp, harbored in leaves of  a Cameroonian 
medicinal plant Garcinia nobilis Engl. (Clusiaceae). Garcin-
ia, one of  the biggest genera of  the family Guttiferae, has 
been found to be a rich source of  xanthones,7 biflavo-
noids, benzophenones8 as well as triterpenoids.9 Phenolic 
constituents from Garcinia species have been reported to 
possess various biological activities, including antibacte-
rial,10,11,12 cytotoxic13,14 and pro-oxidant15 activities. They 
also displayed inhibitory activity against α-glucosidase, 
glycation16 and human immunodeficiency virus (HIV).17
The present study was therefore designed to evaluate the 
cytotoxic and antibacterial activities of  secondary metab-
olites from the culture media of  Penicillium sp. isolated 
from the healthy leaf  of  Gacinia nobilis. Details of  their 
antibacterial properties against Gram-negative multi-drug 
resistance bacteria such as Vibrio cholerae and Shigella flex-
neri, as well as their cytotoxic activities against HeLa (can-





The high resolution mass spectra were obtained with 
an LTQ-Orbitrap Spectrometer (Thermo Fisher, USA) 
equipped with a HESI-II source. The spectrometer was 
operated in positive mode (1 spectrum s-1; mass range: 
100-1000) with nominal mass resolving power of  60 000 
at m/z 400 with a scan rate of  1 Hz). It was equipped with 
automatic gain control to provide high-accuracy mass 
measurements within 2 ppm deviation using an internal 
standard; Bis(2-ethylhexyl)phthalate : m/z = 391.28428. 
The spectrometer was attached with an Agilent (Santa 
Clara, USA) 1200 high performance liquid chromatog-
raphy (HPLC) system consisting of  LC-pump, photo-
diode array (PDA) detector (λ = 260 nm), auto sampler 
(injection volume 5 μ L) and column oven (30 °C). The 
following parameters were used for experiments: spray 
voltage 5 kV, capillary temperature 260 °C, tube lens 70 
V. Nitrogen was used as sheath gas (50 arbitrary units) 
and auxiliary gas (5 arbitrary units). Helium served as the 
collision gas. The separations were performed by using 
a Nucleodur C18 Gravity column (50 x 2 mm, 1.8 µm 
particle size) with a H2O (+ 0.1% HCOOH) (A) / aceto-
nitrile (+ 0.1% HCOOH) (B) gradient (flow rate 300 μL/
min). Samples were analyzed using a gradient program 
as follows: 95% A isocratic for 10 min, linear gradient to 
100% B over 14 min, after 100% B isocratic for 4 min, 
the system returned to its initial condition (80% A) within 
0.5 min, and was equilibrated for 4.5 min. The separation 
was carried out by preparative HPLC run for 20 min on a 
Gilson apparatus with ultra-violet (UV) detection at 220 
nm using a Nucleodur C18 Isis column (Macherey-Nagel, 
Düren, Germany), 5 μm (250 × 16 mm) with a H2O (A) 
/ CH3OH (B) gradient (flow rate 4 mL/min). Samples 
were separated by using a gradient program as follows: 
60% A isocratic for 2 min, linear gradient to 100% B over 
18 min, after 100% B isocratic for 5 min, the system re-
turned to its initial condition (60% A) within 0.50 min, 
and was equilibrated for 4.50 min. The Nuclear magnetic 
resonance (NMR) spectra were recorded on a Bruker 
DRX-500 MHz spectrometer
 
Sampling of Garcinia nobilis
Leaves of G. nobilis were collected in Mount Etinde, 
Southwest region Cameroon. The plant material was 
identified at the Cameroon National Herbarium, Yaoun-
dé, where the voucher specimen (50779/HNC/Cam/Mt 
Zamangoue) is deposited.
 
Isolation and identification of  the endophytic fun-
gus
The healthy leaf  was firstly cleaned by washing several 
times under running tap water and  then cut into small 
slices, followed by successive surface sterilization in 70% 
ethanol and NaOCl (6-14% active chlorine) for 2 min and 
finally with sterile distilled water for three times. Plant 
material was then dried in between the folds of  sterile 
filter papers and deposited on a Petri dish containing 
potato dextrose agar (PDA) medium (200 g potato, 20 
g dextrose, and 15 g agar in 1 L of  H2O, supplemented 
with 100 mg/L of  chloramphenicol to suppress bacte-
rial growth) and incubated at 25 °C until the outgrowth 
of  endophytic fungi was discerned. Hyphal tips originat-
ing from plant segments were transferred to potato dex-
trose agar (PDA). Each fungal isolate was checked for 
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purity and transferred to the new medium by the hyphal 
tip method. A total of  eight fungi were morphologically 
distinguishable. One of  these isolates, CAM64 was se-
lected for further studies based on it morphotype and the 
LC-MS profile of  its crude extract from small scale fer-
mentation. The fungus was identified as Penicillium sp. 
according to morphologic traits and a molecular biologi-
cal protocol by DNA amplification and sequencing as de-
scribed by Douanla et al (2013).18
 
Fermentation, extraction and isolation of  secondary 
metabolites
Fermentation was done on a shaker for 10 days at 25oC 
in 500 mL x 10 Erlenmeyer flasks each containing 300 
mL of  sterile potato dextrose broth (PDB) medium.19 
Its solid state fermentation was done in 10 flasks (1 L 
each), each flask containing 100 g rice and 100 mL water 
enriched with 0.3% peptone and extracted after 40 days 
growing at 25oC with ethyl acetate to yield 3.2 g of  crude 
extract. Isolation of  penialidins (A-C) and citromycetin 
(1-4) was carried out as previously described.19 Isola-
tion of  hydroxyphenylglyoxalaldoxime (5) and brefelfin 
A (6) was done as follow. From solid state fermentation 
of  Penicillium sp., the ethyl acetate crude extract (3.2g) 
was firstly partitioned with cyclohexane to remove fat-
ty material. The resulted polar fraction (1.8 g) was then 
subjected to column chromatography using sephadex 
LH-20 to afford four main fractions (Fr1-Fr4) after thin 
layer chromatography (TLC) monitoring. Fractions Fr2 
(96 mg) and Fr3 (105 mg) were purified by preparative 
HPLC eluting with a gradient of  methanol-H2O+ 0.1% 
trifluoroacetic acid (TFA) to yield hydroxyphenylglyoxal-
aldoxime (5) C8H8O3N (4.6 mg, tR = 6.73 min, high-res-
olution electron impact-mass spectrometry (HRESIMS) 
at 166.05022 [M+H]+: (calcd. 166.05042) and brefelfin 
A (6) C16H24O4 (3.5 mg, tR = 12.06 min, HRESIMS at 
281.17957 [M+H]+: (calcd. 281.17528). Their structures 
(Fig. 1) were easily determined from their high resolution 
mass spectrometry combined to proton and carbon 13 
nuclear magnetic resonance (1H and 13C-NMR), by intro-
ducing these data into antibase20 and finally confirmed by 
two-dimension nuclear magnetic resonance (2D NMR) 
spectra. The chemical shifts were in agreement with those 
reported in the literature.21
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Antibacterial assays
Microbial growth conditions
A total of  five bacterial strains were tested for their sus-
ceptibility to compounds, and these strains were taken 
from our laboratory collection (kindly provided by Dr. 
T. Ramamurthy, NICED, Kolkata). Among the clinical 
strains of  Vibrio cholerae used in this study, strains NB2 and 
SG24(1) belonged to O1 and O139 serotypes, respective-
ly. These strains were able to produce cholera toxin and 
hemolysin.  The other strains used in this study were V. 
cholerae non-O1, non-O139 (strains CO6 and PC2); and 
Shigella flexneri SDINT. The V. cholerae non-O1 and non-
O139 strains, were positive for hemolysin production 
but negative for cholera toxin production. The bacterial 
strains were maintained on agar slant at 4 °C and subcul-
tured on a fresh appropriate agar plates 24 h prior to any 
antibacterial test. The Mueller Hinton Agar (MHA) was 
used for the activation of  bacteria. The Mueller Hinton 
Broth (MHB) and nutrient agar (Hi-Media) were used for 
the MIC and MBC determinations respectively.
 
Inocula preparation
Suspensions of  bacteria were prepared in MHB from 
cells arrested during their logarithmic phase growth (4h) 
on MHB at 37 °C. The turbidity of  the microbial suspen-
sion was read spectrophotometrically at 600 nm and ad-
justed to an OD of  1.0 with MHB, which is equivalent to 
2×108 CFU/mL. From this prepared solution, other dilu-
tions were made with MHB to yield 1x106 CFU/mL.22
 
Determination of  minimum inhibitory concentra-
tion (MIC) and minimum bactericidal concentration 
(MBC)
MIC and MBC of  compounds 1-6 were assessed using 
the broth microdilution method recommended by the 
National Committee for Clinical Laboratory Standards23,24 
with slight modifications. Each test sample was dissolved 
in dimethylsulfoxide (DMSO) to give a stock solution. 
The 96-well round bottom sterile plates were prepared by 
dispensing 180 µl of  the inoculated broth (1x106CFU/
mL) into each well. A 20 µL aliquot of  the compounds 
was added. The concentrations of  sample tested were 
0.125, 0.25, 0.50, 1, 2, 4, 8, 16, 32, 64, 128, 256, 512, 1024, 
and 2048 µg/mL. The final concentration of  DMSO in 
each well was < 1% [preliminary analyses with 1% (v/v) 
DMSO did not inhibit the growth of  the test organisms]. 
Dilutions of  ampicillin and chloramphenicol served as 
positive controls, while broth with 20 µL of  DMSO was 
used as negative control. Plates were covered and incu-
bated for 24 h at 37°C. After incubation, minimum in-
hibitory concentrations (MIC) were read visually; all wells 
were plated to nutrient agar (Hi-Media) and incubated for 
24 h at 37 °C. The lowest concentrations that yielded no 
growth after this subculturing were taken as the minimum 
bactericidal concentration (MBC) values.
 
Anticancer assays
HeLa (Human cervical cancer cell line, ATCC No. CCL-
2) and monkey Vero cells (normal non-cancer cells, 
ATCC No. CCL-81), obtained from the American Type 
Culture Collection (ATCC) were used in this study. An-
ticancer activity was determined using the 3-(4,5dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 
Sigma, USA) assay reported by Mosmann25 for the hu-
man cervical cancer cell lines (HeLa cells) and monkey 
Vero cells. This cell viability assay is based on living cells’ 
property to transform the MTT dye tetrazolium ring into 
a purple-colored formazan structure due to the action of  
mitochondrial and other dehydrogenases inside the cell. 
The color intensity yielded by the cell population is di-
rectly proportional to the number of  viable cells, and one 
can quantify the absorbance measurements using mathe-
matical parameters. Each test sample was dissolved in di-
methylsulfoxide (DMSO) to give a stock solution. Com-
pounds 1-6 were prepared from the stock solutions by 
serial dilution in RPMI 1640 to give a volume of  100 µL 
in each well of  a microtiter plate (96-well). Each well was 
filled with 100 µL of  cells at 2 × 105 cells/mL. The assay 
for each concentration of  compound was performed in 
triplicates and the culture plates were kept at 37°C with 
5% (v/v) CO2 for 24 hours. After removing the super-
natant of  each well and washing twice by PBS, 20 μL of  
MTT solution (5 mg/ mL in PBS) and 100 μL of  medium 
were then introduced. After 4 h of  incubation, 100 µL 
of  DMSO was added to each well to dissolve the forma-
zan crystals and the absorbance values at 490 nm were 
measured with a microplate reader (Bio-RAD 680, USA). 
The relative cell viability (%) was expressed as a relative 
percentage of  treated cells to the untreated control cells 
(TC/UC x 100). The rate of  cell inhibition was calculated 
using the following formula: inhibition rate = [1- (ODtest/
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ODnegative control)] ×100%. The LC50 values were calculated 
as the concentration of  test sample resulting in a 50% re-
duction of  absorbance compared to untreated cells. Cells 
treated with paclitaxel + RPMI 1640 served as positive 
control whereas cells left untreated + 1% (v/v) DMSO + 
RPMI 1640 were used as negative control.
 
Hemolytic assay
Whole blood (10 mL) from a healthy individual was col-
lected into a conical tube containing heparin as an anti-
coagulant (blood group O was used). Authorization for 
the collection of  blood was obtained from the Medical 
and Ethical Committee. The written informed consent 
for participation in the study was obtained from a parent 
of  40 years old.  Erythrocytes were harvested by cen-
trifugation for 10 min at 1,000 x g at room temperature 
and washed three times in PBS solution. The top layer 
(plasma) and the next, milky layer (buffy coat with a layer 
of  platelets on top of  it) were then carefully aspirated and 
discarded. The cell pellet was resuspended in 10 mL of  
PBS solution and mixed by gentle aspiration with a Pas-
teur pipette. This cell suspension was used immediately.
Hemolysis test was performed to determine cellular tox-
icity of  the compounds as previously described.26 Com-
pounds 1-6, at concentrations ranging from 0.25 to 512 
µg/mL, were incubated with an equal volume of  1% hu-
man red blood cells in phosphate buffered saline (10 mM 
PBS, pH 7.4) at 37°C for 1 h. 1% human red blood cells 
in buffer was used as a non-hemolytic control whereas 
buffer containing 1% Triton X-100 and 1% human red 
blood cells served as a 100% hemolytic control. Cell lysis 
was monitored by measuring the release of  hemoglobin 
at 595 nm with a spectrophotometer (Thermo Scien-
tific, USA). Percent hemolysis was calculated as follows: 
[(A595 of  sample treated with compound - A595 of  sam-
ple treated with buffer) / (A595 of  sample treated with 




Statistical analysis was carried out using Statistical Pack-
age for Social Science (SPSS, version 12.0). The experi-
mental results were expressed as the mean ± Standard 
Deviation (SD). Group comparisons were performed us-
ing One Way ANOVA followed by Waller-Duncan Post 





Compounds 1-6 were examined in vitro against bacterial 
species and the results are depicted in Table 1. All com-
pounds showed different degrees of  antibacterial activi-
ties against the tested bacterial pathogens. Vibrio cholerae 
SG24 (1) was the most sensitive bacteria while Vibrio chol-
erae CO6 was the most resistant. Compound 3 (MIC = 
0.50-16 μg/mL) was the most active among the isolated 
compounds following in decreasing order by compound 
2 (MIC = 4-32 μg/mL), compound 1 (MIC = 8-32 μg/
mL), compound 5 (MIC = 32-64 μg/mL), compounds 4 
and 6 (MIC = 64-128 μg/mL). 
The antibacterial activities of  compounds 1-6 (MIC = 8 
– 32 µg/mL) were in some cases equal to or more im-
portant than those of  ampicillin and chloramphenicol; 
highlighting their good antibacterial potency. Collectively, 
these findings showed that compounds 1-6 have broad-
spectrum antibacterial activity and are effective against 
ampicillin-resistant and chloramphenicol-resistant bacte-
ria. The lowest MIC value of  0.50 μg/mL was recorded 
on Vibrio cholera SG24 (1) and Shigella flexneri with 
compound 3 while the lowest MBC value of  1μg/mL 
was obtained on Vibrio cholerae SG24 (1) with compound 
3. However, the highest MIC value of  128 μg/mL was 
recorded on Vibriocholerae CO6, Vibrio cholerae NB2 and 
Vibrio cholerae PC2 with compound 3 and on Vibrio chol-
erae CO6, Vibrio cholerae NB2, Shigella flexneri with com-
pound 6 while the highest MBC value of  256 μg/mL was 
obtained on Vibrio cholerae CO6 and Vibrio cholerae PC2 
with compound 6. A lower MBC/MIC (≤4) value signi-
fies that a minimum amount of  compound is used to kill 
the microbial species, whereas, a higher value signifies the 
use of  comparatively more amount of  compound for the 
control of  any microorganism. No activity was noted for 
ampicillin against Vibrio cholerae NB2, Vibrio cholerae PC2, 
Shigella flexneri SDINT at concentrations up to 512 µg/
mL. However, these multi-drug resistant bacterial strains 
were sensitive to compounds 1-6. This finding suggests 
the antibacterial potency of  these compoundsin particu-
lar for the treatment of  ampicillin-resistant and chloram-
phenicol-resistant bacteria.
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Hemolytic activity
In this study, none of  the tested compounds showed he-
molytic activities against human red blood cells at con-
centrations up to 512 µg/mL (results not shown) indicat-
ing that they are non-toxic to normal cells.  
 
Anticancer activity
Compounds 1-6 were evaluated for their cytotoxicity 
against human cancer cells (HeLa cells) and normal non-
cancer cells (Vero cells) and the results are summarized 
in Table 2. The isolated compounds exhibit an inhibitory 
effect against tumor cell growth, with varying efficien-
cies (LC50 = 0.88 – 9.21 µg/mL) and selectivities (SI = 
19.70– 315.47). The lowest LC50 value (corresponding 
to the most anticancer compound) was found with com-
pound 6 followed in decreasing order by compound 5 > 
compound 3, compound 4 > compound 1, compound 2. 
The tested compounds also showed significant anticancer 
activity to HeLa cells (LC50 = 0.88 – 9.21 µg/mL) when 
compared with Vero cells (LC50 = 124.72 - 277.62 µg/
mL) indicating that they are less toxic to normal cells. The 
positive control paclitaxel showed LC50 values of  0.57 and 
68.51 µg/mL against HeLa and Vero cells, respectively.
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Table 1 Inhibition parameters (MIC, MBC) of compounds 1-6 and reference  
antibacterial drugs (µg/mL) 
 
Antibacterial activity (MIC and MBC in µg/mL) 



















MIC 8 16 32 32 16 
MBC 16 32 64 64 32 
MBC/MIC 2 2 2 2 2 
2  
 
MIC 4 32 16 8 16 
MBC 4 64 16 8 32 
MBC/MIC 1 2 1 1 2 
3  
 
MIC 0.50 16 8 0.50 8 
MBC 1 32 16 2 16 
MBC/MIC 2 2 2 4 2 
4 
 
MIC 64 128 128 128 64 
MBC 64 128 128 128 64 
MBC/MIC 1 1 1 1 1 
5 MIC 64 64 32 32 32 
 MBC 128 128 64 64 64 
 MBC/MIC 2 2 2 2 2 
6 MIC 64 128 64 128 128 
 MBC 4 256 64 256 128 
 MBC/MIC 1 2 1 2 1 
Ampicillin  MIC 16 16 >512 >512 >512 
MBC 16 16 >512 >512 >512 
MBC/MIC 1 1 / / / 
Chloramphenicol  MIC 4 16 8 1 64 
MBC 8 64 32 4 >512 
MBC/MIC 2 4 4 4 / 
 
/: not determined; MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration 
Discussion
The findings of  the present study showed that the anti-
bacterial activities varied with the bacterial strains. These 
variations may be due to genetic differences between the 
bacteria. The results of  MIC and MBC showed that the 
MIC values obtained were four times equal to or lesser 
than the MBCs on the corresponding (sensitive) bacteria, 
suggesting the bactericidal effects of  the concerned sam-
ples.27,28,29 This is interesting in view of  the perspective 
of  developing new antibacterial drugs from endophytic 
fungus. The present study showed antibacterial activity of  
penialidin A-C (1-3), citromycetin (4), p-hydroxyphenylg-
lyoxalaldoxime (5) and brefelfin A (6) from Penicillium sp. 
against the bacterial species and this is the first report on 
the activity of  these compounds against these types of  
pathogenic strains. However, the results of  compounds 1 
and 2 are in agreement with those of  the literature against 
Staphylococcus aureus, Escherichia coli, Bacillus subtilis, Acineto-
bacter sp.19 
Although no definite structure-activity relationship could 
be determined, some structural features that might have 
influenced the antibacterial activity of  polyketide com-
pounds (1-4) can be drawn from the comparison of  the 
chemical structures of  compounds with different activi-
ties. Compound 3 was the most active polyketide com-
pound, followed by 2, 1 and 4. Together, it appears that, 
2-hydroxyl, 2-methoxy and 10-carboxyl groups play a 
greater role in increasing the antimicrobial activity based 
on the substitution patterns of  the aromatics rings. The 
overall results of  this study can be considered as very 
promising in the perspective of  new drugs discovery from 
endophytic fungus sources, especially when the medical 
importance of  tested bacteria is considered. Acute watery 
diarrhea accounts for 80% of  the cases (death account 
for 50%) in the developing world.30 
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Table 2 Anticancer (LC50 in μg/mL) of compounds from 1-6 and their selectivity index (SI). 
Compounds Cytotoxicty (LC50 in μg/mL)  Selectivity Index* 

















1 6.33 ± 0.66a 124.72 ± 1.27a 19.70 15.59 7.79 3.89 3.89 7.79 
2 6.74 ± 0.27a 158.24 ± 2.86b 23.47 39.56 4.94 9.89 19.78 9.89 
3 8.13 ± 0.18b 233.26 ± 3.73c 28.69 466.52 14.57 29.15 466.52 29.15 
4 9.21 ± 0.79b 261.14 ± 2.87d 28.35 4.08 2.04 2.04 2.04 4.08 
5 2.06 ± 0.23c 195.41 ± 1.79e 94.85 3.05 3.05 6.10 6.10 6.10 
6 0.88 ± 0.12d 277.62 ± 1.38f 315.47 4.33 2.16 4.33 2.16 2.16 
Paclitaxel 0.57 ± 0.03e  68.51 ± 0.19g 120.19 / / / / / 
 
/: not determined, SI = LC50 on Vero cells /MIC or LC50 on HeLa cells; *: SI obtained from average MIC. Each LC50 
value represents the mean ± SD (n = 3). In the same column, LC50 values marked with different superscript letters 
(a-g) are significantly different (p < 0.05). 
Among the diarrheal diseases, cholera is a serious epi-
demic disease caused by the gram-negative bacterium 
Vibrio cholerae.31 Vibrio cholerae, serotypes O1 and O139 
has ability to produce an enterotoxin, cholera toxin that is 
a major determinant of  virulence for cholera. Among the 
other virulence factors, ElT or hemolysin produced by 
Vibrio cholerae is also reportedly a potent toxin with both 
enterotoxic and cytotoxic activities.32,33 Emergence of  
multiply drug-resistant Vibrio cholerae is a serious clinical 
problem in the treatment and containment of  the disease, 
as reflected by the increase in the fatality rate from 1% 
to 5.3% after the emergence of  drug-resistant strains in 
Guinea-Bissau during the 1996–1997 epidemic of  chol-
era.34 Such findings trace the importance of  discovering 
new substances against which these organisms are sensi-
tive. Generally, these bacterial strains were sensitive to the 
isolated compounds.
MTT assay measures the cell viability based on the reduc-
tion of  yellow tetrazolium MTT to purple formazon dye 
by mitochondrial dehydrogenase enzyme. The amount 
of  formazon reflects the number of  metabolically ac-
tive viable cells.35 Compound 3 was the most antibacte-
rial compound while compounds 5 and 6 were the most 
anticancer samples. Interestingly, the anticancer of  com-
pounds 5 and 6 can be considered more important when 
taking into consideration the criterion of  the American 
National Cancer Institute (NCI) regarding the antican-
cer of  pure compounds (LC50 < 4 µg/mL).
36 The results 
of  the anticancer activity also showed that the isolated 
compounds exhibit an inhibitory effect against tumor cell 
growth, with varying efficiencies (LC50 = 0.88 – 9.21 µg/
mL) and selectivities (SI = 19.70– 315.47). The anticancer 
mechanisms associated to each compound may explain 
the cytotoxic potency of  these compounds. Selectivity is 
important because most anticancer drugs currently in use 
induce serious adverse effects. In this study, Selectivity 
Index (SI) of  active compounds was determined in order 
to investigate whether the cytotoxic activity was specific 
to cancer cells/bacterial strains. The SI of  the samples is 
defined as the ratio of  cytotoxicity (LC50 values) on nor-
mal non-cancer cells (Vero cells) to cancer cells (HeLa 
cells) or bacterial cells: SI = LC50 on Vero cells / LC50 on 
HeLa cells or MIC. Test agents with SI higher than three 
were considered to have good selectivity towards cancer 
cells.37 The SI values of  the tested compounds against 
the HeLa cells ranged from 19.70 to 315.47 and could 
be considered as good. Apart from compounds 4 on V. 
cholerae CO6, V. cholerae NB2 and V. cholerae PC2 and 
compound 6 on V. cholerae CO6, V. cholerae PC2 and S. 
flexneri, the SI values of  the tested compounds against 
the bacterial strains ranged from 3.05 to 466.52 and could 
be considered as high.
Conclusion
The chemical analysis of  the ethyl acetate extract of  Peni-
cillium sp., an endophytic fungus associated with leaves of  
Garcinia nobilis afforded six known compounds including 
penialidin A-C (1-3), citromycetin (4), p-hydroxyphenyl-
glyoxalaldoxime (5) and brefelfin A (6). Compounds 1-6 
showed good antibacterial and anticancer activities with 
no toxicity to human red blood cells and normal Vero 
cells. These compounds could be explored in more de-
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